Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
GW Pharmaceuticals
Biotech
Encoded bags $135M to push 'precision gene therapy' into phase 1
Encoded Therapeutics raised $135 million to advance a precision gene therapy that could address more symptoms of Dravet syndrome than seizures.
Amirah Al Idrus
Jul 22, 2020 6:00am
After Dravet hiccup, Zogenix's Fintepla logs Lennox-Gastaut win
Feb 7, 2020 10:45am
Zogenix data blunder trips up FDA filing for epilepsy drug Fintepla
Apr 9, 2019 6:54am
Ovid, Takeda add 2 rare epilepsies to rare drug pact
Jul 18, 2018 10:56am
Chasing GW, Zogenix scores a win in second Dravet phase 3
Jul 12, 2018 9:10am
Kalytera's cannabis-based GVHD drug gathers steam
Jun 21, 2018 10:04am
